Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Tamiflu (Oseltamivir Phosphate) Oral Suspension & Capsule
Company: Hoffmann-La Roche Inc.
Application No.: 021087s010 & 021246s007
Approval Date: 04/26/2002


Date created:  June 22, 2007

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.